E-Book, Englisch, 337 Seiten, eBook
E-Book, Englisch, 337 Seiten, eBook
ISBN: 978-1-4614-7940-6
Verlag: Springer US
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
is to provide current information on advances in the field of endocannabinoid signaling and potential therapeutic applications with a particular emphasis on monoaminergic circuits.
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Endocannabinoids and monoamines: modulating the modulators.- Endocannabinoid-mediated synaptic plasticity.- Current cannabinoid receptor nomenclature and pharmacological principles.- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction.- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders.- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers.- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion.- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function.- Endocannabinoids, Monoamines and Stress.- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders.- Endocannabinoid Signaling and the Regulation of theSerotonin System.- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors.- Involvement of serotonergic system in cannabinoid analgesia.- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.